Company Spotlight

Almac Group

Almac House, 20 Seagoe Industrial Estate
Armagh, BT63 5QD
United Kingdom
View Profile


Contract Service Directory


Toxikon





Company Headquarters

15 Wiggins Ave
Bedford, MA 01730
United States

Company Description

Toxikon is a leading preclinical contract research organization (CRO) providing in vivo, in vitro, and analytical testing services for the medical device, biotechnology, and pharmaceutical industries - helping those companies gain approval for their products quickly and bring them to market successfully.

Contract Service Directory

    Related Content

    • Clinical Trials | CRO News | Laboratory Testing | Toxicology
      Navigating a Competitive CRO Landscape

      Navigating a Competitive CRO Landscape

      Jacob McDonald of Lovelace Biomedical looks at consolidation in an increasingly competitive environment
      Jake McDonald, Ph.D., Chief Scientific Officer, Lovelace Biomedical 11.15.19

    • Analytical Services | Industry News | Laboratory Testing
      Sterigenics Acquires Toxikon’s European Lab Biz

      Sterigenics Acquires Toxikon’s European Lab Biz

      Acquisition creates leading extractables and leachables lab testing platform
      11.02.17

    • Breaking News | Drug Discovery | Validation

      Toxikon, Ocean Ridge Biosciences In Services Partnership

      To globally market respective discovery/development expertise
      10.27.11


    • Breaking News | Chemistry | CRO News | Industry News | Laboratory Testing | Preclinical Outsourcing

      Toxikon Expands ESRS

      Preclinical CRO begins construction on expanded Efficacy and Ssurgical Research Services wing
      Gil Roth 06.27.11

    • Breaking News | Promotions & Moves

      BASi

      BASi (Bioanalytical Systems Inc.) has added three representatives to its business development team.
      12.03.10

    • Breaking News | Drug Discovery | Industry News | Toxicology

      Toxikon Completes Tox Studies for Cellceutix

      Toxikon Corp. has completed toxicity studies in two species for Cellceutix Corp.’s Kevetrin, a compound in development for the treatment of resistant lung and breast cancers.
      11.03.10


    • Breaking News | Industry News | Toxicology

      Toxikon Adds Cancer Assay

      Toxikon has added the Comet Assay IV Analysis System developed by Perceptive Instruments to its genetic and molecular toxicology study offerings.
      09.02.10

    • Breaking News | Industry News | Toxicology

      Toxikon Expands Immunotoxicology Services

      Toxikon Corp. has expanded its immunotoxicology offerings, adding flow cyctometry, which enables the direct analysis of cells to detect a variety of specifically labeled components.
      09.22.09